A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy)-Reference-Cited by-同舟云学术

A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy)

Published:2018-10 Issue: Volume:277 Page:369-376
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Descamps Olivier S.,Van Caenegem Olivier,Hermans Michel P.,Balligand Jean-Luc,Beauloye Christophe,Bondue Antoine,Carlier Stéphane,Castermans Emilie,Chenot Fabien,Claeys Marc,De Block Christophe,de Leener Anne,De Meester Antoine,Demeure Fabian,De Raedt Herbert,Desmet Walter,Elegeert Ivan,Guillaume Michel,Hoffer Etienne,Kacenelenbogen Raymond,Lancellotti Patrizio,Langlois Michel,Leone Attilio,Mertens Ann,Paquot Nicolas,Vanakker Olivier,Vanoverschelde Jean-Louis,Verhaegen Ann^ORCID,Vermeersch Pieter,Wallemacq Caroline,Rietzschel Ernst

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

2. High prevalence of a novel mutation in exon 4 in the LDL receptor gene in Belgium;Descamps;Clin. Genet.,1997

3. Impact of genetic defects on atheroclerosis in patients suspected of familial hypercholesterolemia;Descamps;Eur. J. Clin. Invest.,2001

4. Impact of Genetic Defects on coronary atherosclerosis in patients suspected of familial hypercholesterolemia;Descamps;Eur. J. Clin. Invest.,2003

5. Clinical and preclinical myocardial ischaemia in familial hypercholesterolemia;Descamps;Atherosclerosis,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term safety and effectiveness of alirocumab and evolocumab in familial hypercholesterolemia (FH) in Belgium;Acta Cardiologica;2023-09-28

2. Genetic Testing for Familial Hypercholesterolemia in Clinical Practice;Current Atherosclerosis Reports;2023-04-15

3. A Systematic Review of Lipid Management in Secondary Prevention and Comparison of International Lipid Management Pathways;Cureus;2023-02-25

4. Developing measures to capture the true value of primary care;BJGP Open;2021-02-09

5. Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives;Atherosclerosis Supplements;2020-12